Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II-III esophageal squamous cell carcinoma

OBJECTIVE: Definitive chemoradiotherapy (CRT) remains the most commonly used treatment for locally advanced esophageal squamous cell carcinoma (SCC), owing to perceptions that esophagectomy offers an unclear survival advantage. We compare recurrence, overall survival (OS), and disease-free survival...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Thorac Cardiovasc Surg
Glavni autori: Barbetta, Arianna, Hsu, Meier, Tan, Kay See, Stefanova, Dessislava, Herman, Koby, Adusumilli, Prasad S., Bains, Manjit S., Bott, Matthew J., Isbell, James M., Janjigian, Yelena Y., Ku, Geoffrey Y., Park, Bernard J., Wu, Abraham J., Jones, David R., Molena, Daniela
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5960990/
https://ncbi.nlm.nih.gov/pubmed/29548582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.01.086
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items